High-flow oxygen therapy versus facemask preoxygenation in anticipated difficult airway management (PREOPTI-DAM): an open-label, single-centre, randomised controlled phase 3 trial.
- DOI
- 10.1016/j.eclinm.2023.101998
- Published
- 2023-05-22
- Container
- EClinicalMedicine
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- supportingDirectory of Open Access Journals: A matching record was returned by DOAJ.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.eclinm.2023.101998,
title = {High-flow oxygen therapy versus facemask preoxygenation in anticipated difficult airway management (PREOPTI-DAM): an open-label, single-centre, randomised controlled phase 3 trial.},
author = {Vourc'h M and Huard D and Le Penndu M and Deransy R and Surbled M and Malidin M and Mahe PJ and Guitton C and Roquilly A and Malard O and Feuillet F and Rozec B and Asehnoune K.},
year = {2023},
journal = {EClinicalMedicine},
doi = {10.1016/j.eclinm.2023.101998},
url = {https://doi.org/10.1016/j.eclinm.2023.101998}
}RIS
TY - JOUR TI - High-flow oxygen therapy versus facemask preoxygenation in anticipated difficult airway management (PREOPTI-DAM): an open-label, single-centre, randomised controlled phase 3 trial. AU - Vourc'h M AU - Huard D AU - Le Penndu M AU - Deransy R AU - Surbled M AU - Malidin M AU - Mahe PJ AU - Guitton C AU - Roquilly A AU - Malard O AU - Feuillet F AU - Rozec B AU - Asehnoune K. PY - 2023 JO - EClinicalMedicine DO - 10.1016/j.eclinm.2023.101998 UR - https://doi.org/10.1016/j.eclinm.2023.101998 ER -
APA
M, V., D, H., M, L. P., R, D., M, S., M, M., PJ, M., C, G., A, R., O, M., F, F., B, R., & K., A. (2023). High-flow oxygen therapy versus facemask preoxygenation in anticipated difficult airway management (PREOPTI-DAM): an open-label, single-centre, randomised controlled phase 3 trial.. EClinicalMedicine. https://doi.org/10.1016/j.eclinm.2023.101998
Source records
- europe-pmc · retrieved 2026-09-26T12:56:27.398Z
- doaj · retrieved 2026-09-26T12:56:27.371Z
- hal · retrieved 2026-09-26T12:56:27.423Z